Regenxbio Inc buy BiotechBee
Start price
08.09.24
/
60%
€10.30
Target price
28.02.27
€16.00
Performance (%)
-22.82%
End price
14.12.24
€7.95
Summary
This prediction ended on 14.12.24 with a price of €7.95. The prediction for Regenxbio Inc disappointed with a performance of -22.82%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regenxbio Inc | -2.211% | -2.211% | 17.099% |
| iShares Core DAX® | 2.334% | 1.011% | 10.406% |
| iShares Nasdaq 100 | 1.370% | -3.612% | 27.400% |
| iShares Nikkei 225® | 2.437% | -7.461% | 49.840% |
| iShares S&P 500 | 1.259% | 0.677% | 23.666% |
According to BiotechBee what are the pros and cons of Regenxbio Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Regenxbio Inc diskutieren
Buy mit Kursziel 16,0